{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:23:05Z","timestamp":1760955785652},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science Technology Innovation Project in Shaanxi .","award":["2016KTZDSF01-07"],"award-info":[{"award-number":["2016KTZDSF01-07"]}]},{"name":"China Natural Sciences Foundation","award":["81572974"],"award-info":[{"award-number":["81572974"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00705-018-3797-7","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T01:00:43Z","timestamp":1522112443000},"page":"1851-1861","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71"],"prefix":"10.1007","volume":"163","author":[{"given":"Xi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaowei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huizhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"3797_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","volume":"129","author":"NJ Schmidt","year":"1974","unstructured":"Schmidt NJ, Lennette EH, Ho HH (1974) An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129:304\u2013309","journal-title":"J Infect Dis"},{"key":"3797_CR2","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1016\/j.vaccine.2012.03.010","volume":"30","author":"YP Li","year":"2012","unstructured":"Li YP, Liang ZL, Gao Q et al (2012) Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial. Vaccine 30:3295\u20133303","journal-title":"Vaccine"},{"key":"3797_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1017\/S0950268809991555","volume":"138","author":"SS Wong","year":"2010","unstructured":"Wong SS, Yip CC, Lau SK et al (2010) Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect 138:1071\u20131089","journal-title":"Epidemiol Infect"},{"key":"3797_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3345\/kjp.2016.59.10.395","volume":"59","author":"KY Lee","year":"2016","unstructured":"Lee KY (2016) Enterovirus 71 infection and neurological complications. Korean J Pediatr 59:395\u2013401","journal-title":"Korean J Pediatr"},{"key":"3797_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S1474-4422(08)70207-2","volume":"7","author":"J Qiu","year":"2008","unstructured":"Qiu J (2008) Enterovirus 71 infection: a new threat to global public health? Lancet Neurol 7:868\u2013869","journal-title":"Lancet Neurol"},{"key":"3797_CR6","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/JCM.00630-09","volume":"47","author":"SW Huang","year":"2009","unstructured":"Huang SW, Hsu YW, Smith DJ et al (2009) Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin Microbiol 47:3653\u20133662","journal-title":"J Clin Microbiol"},{"key":"3797_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3201\/eid1501.080264","volume":"15","author":"S AbuBakar","year":"2009","unstructured":"AbuBakar S, Sam IC, Yusof J et al (2009) Enterovirus 71 outbreak, Brunei. Emerg Infect Dis 15:79\u201382","journal-title":"Emerg Infect Dis"},{"key":"3797_CR8","doi-asserted-by":"publisher","first-page":"e96051","DOI":"10.1371\/journal.pone.0096051","volume":"9","author":"W Liu","year":"2014","unstructured":"Liu W, Wu S, Xiong Y et al (2014) Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China. PLoS One 9:e96051","journal-title":"PLoS One"},{"key":"3797_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/1040841X.2011.580723","volume":"37","author":"L Yi","year":"2011","unstructured":"Yi L, Lu J, Kung HF et al (2011) The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol 37:313\u2013327","journal-title":"Crit Rev Microbiol"},{"key":"3797_CR10","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","volume":"29","author":"CC Liu","year":"2011","unstructured":"Liu CC, Chou AH, Lien SP et al (2011) Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Vaccine 29:4362\u20134372","journal-title":"Vaccine"},{"key":"3797_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2013.11.020","volume":"180","author":"H Zhang","year":"2014","unstructured":"Zhang H, Cong H, Song L et al (2014) The nuclear protein Sam68 is redistributed to the cytoplasm and is involved in PI3K\/Akt activation during EV71 infection. Virus Res 180:1\u201311","journal-title":"Virus Res"},{"key":"3797_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/13550280591002531","volume":"11","author":"G Palacios","year":"2005","unstructured":"Palacios G, Oberste MS (2005) Enteroviruses as agents of emerging infectious diseases. J Neurovirol 11:424\u2013433","journal-title":"J Neurovirol"},{"key":"3797_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.virusres.2014.07.026","volume":"192","author":"H Zhang","year":"2014","unstructured":"Zhang H, Li F, Pan Z et al (2014) Activation of PI3K\/Akt pathway limits JNK-mediated apoptosis during EV71 infection. Virus Res 192:74\u201384","journal-title":"Virus Res"},{"key":"3797_CR14","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.1016\/j.vaccine.2010.08.080","volume":"28","author":"JN Liu","year":"2010","unstructured":"Liu JN, Wang W, Duo JY et al (2010) Combined peptides of human enterovirus 71 protect against virus infection in mice. Vaccine 28:7444\u20137451","journal-title":"Vaccine"},{"key":"3797_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.14715\/cmb\/2016.62.13.7","volume":"62","author":"X Peng","year":"2016","unstructured":"Peng X, Fang X, Li J et al (2016) Enhancing immune responses of EV71 VP1 DNA vaccine by co-inoculating plasmid IL-12 or GM-CSF expressing vector in mice. Cell Mol Biol (Noisy-le-grand) 62:35\u201341","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"3797_CR16","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.1016\/j.vaccine.2015.10.103","volume":"33","author":"YI Kim","year":"2015","unstructured":"Kim YI, Song JH, Kwon BE et al (2015) Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection. Vaccine 33:6604\u20136610","journal-title":"Vaccine"},{"key":"3797_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.virol.2016.12.001","volume":"501","author":"P Pushko","year":"2017","unstructured":"Pushko P, Tretyakova I, Hidajat R et al (2017) Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens. Virology 501:176\u2013182","journal-title":"Virology"},{"key":"3797_CR18","first-page":"112","volume":"19","author":"HB Dallas","year":"2016","unstructured":"Dallas HB, Zak A, Khera E et al (2016) Engineering virus-like particles for antigen and drug delivery. Curr Protein Pept Sci 19:112\u2013127","journal-title":"Curr Protein Pept Sci"},{"key":"3797_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.18388\/abp.2016_1275","volume":"63","author":"M Zdanowicz","year":"2016","unstructured":"Zdanowicz M, Chroboczek J (2016) Virus-like particles as drug delivery vectors. Acta Biochim Pol 63:469\u2013473","journal-title":"Acta Biochim Pol"},{"key":"3797_CR20","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1007\/s00253-017-8246-0","volume":"101","author":"X Liu","year":"2017","unstructured":"Liu X, Fang Y, Zhou P et al (2017) Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs. Appl Microbiol Biotechnol 101:4905\u20134914","journal-title":"Appl Microbiol Biotechnol"},{"key":"3797_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12275-017-7058-3","volume":"55","author":"H Jeong","year":"2017","unstructured":"Jeong H, Seong BL (2017) Exploiting virus-like particles as innovative vaccines against emerging viral infections. J Microbiol 55:220\u2013230","journal-title":"J Microbiol"},{"key":"3797_CR22","doi-asserted-by":"publisher","first-page":"40226","DOI":"10.1038\/srep40226","volume":"7","author":"T Mohan","year":"2017","unstructured":"Mohan T, Berman Z, Luo Y et al (2017) Chimeric virus-like particles containing influenza HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against H3N2 viruses. Sci Rep 7:40226","journal-title":"Sci Rep"},{"key":"3797_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12033-016-9987-1","volume":"59","author":"MA Robert","year":"2017","unstructured":"Robert MA, Lytvyn V, Deforet F et al (2017) Virus-like particles derived from HIV-1 for delivery of nuclear proteins: improvement of production and activity by protein engineering. Mol Biotechnol 59:9\u201323","journal-title":"Mol Biotechnol"},{"key":"3797_CR24","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.12659\/MSM.900380","volume":"22","author":"Q Feng","year":"2016","unstructured":"Feng Q, He Y, Lu J (2016) Virus-like particles produced in pichia pastoris induce protective immune responses against coxsackievirus A16 in mice. Med Sci Monit 22:3370\u20133382","journal-title":"Med Sci Monit"},{"key":"3797_CR25","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1016\/j.vaccine.2016.06.058","volume":"34","author":"Q Yan","year":"2016","unstructured":"Yan Q, Wu L, Chen L et al (2016) Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges. Vaccine 34:4196\u20134204","journal-title":"Vaccine"},{"key":"3797_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13104-015-1780-x","volume":"9","author":"X Wang","year":"2016","unstructured":"Wang X, Xiao X, Zhao M et al (2016) EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge. BMC Res Notes 9:42","journal-title":"BMC Res Notes"},{"key":"3797_CR27","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.vaccine.2015.12.069","volume":"34","author":"K Alshaikhahmed","year":"2016","unstructured":"Alshaikhahmed K, Roy P (2016) Generation of virus-like particles for emerging epizootic haemorrhagic disease virus: Towards the development of safe vaccine candidates. Vaccine 34:1103\u20131108","journal-title":"Vaccine"},{"key":"3797_CR28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3748\/wjg.v12.i6.921","volume":"12","author":"YC Chung","year":"2006","unstructured":"Chung YC, Huang JH, Lai CW, Sheng HC, Shih SR, Ho MS, Hu YC (2006) Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol 12:921\u2013927","journal-title":"World J Gastroenterol"},{"key":"3797_CR29","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.vaccine.2015.03.034","volume":"33","author":"C Zhang","year":"2015","unstructured":"Zhang C, Ku Z, Liu Q, Wang X, Chen T, Ye X, Li D, Jin X, Huang Z (2015) High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice. Vaccine 33:2335\u20132341","journal-title":"Vaccine"},{"key":"3797_CR30","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.vaccine.2008.01.058","volume":"26","author":"YC Chung","year":"2008","unstructured":"Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, Chou ST, Hu YC (2008) Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26:1855\u20131862","journal-title":"Vaccine"},{"key":"3797_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.copbio.2007.10.013","volume":"18","author":"C Ludwig","year":"2007","unstructured":"Ludwig C, Wagner R (2007) Virus-like particles-universal molecular toolboxes. Curr Opin Biotechnol 18:537\u2013545","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"3797_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tim.2012.11.006","volume":"2","author":"NM Bell","year":"2013","unstructured":"Bell NM, Lever AM (2013) HIV gag polyprotein: processing and early viral particle assembly. Trends Microbiol 2(3):136\u2013144","journal-title":"Trends Microbiol"},{"key":"3797_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.molimm.2004.06.028","volume":"42","author":"L Deml","year":"2005","unstructured":"Deml L, Speth C, Dierich MP et al (2005) Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses. Mol Immunol 42:259\u2013277","journal-title":"Mol Immunol"},{"key":"3797_CR34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0092-8674(03)00421-5","volume":"113","author":"RA Daniel","year":"2003","unstructured":"Daniel RA, Errington J (2003) Control of cell morphogenesis in bacteria: two distinct ways to make a rod-shaped cell. Cell 113:767\u2013776","journal-title":"Cell"},{"key":"3797_CR35","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","volume":"14","author":"W Xing","year":"2014","unstructured":"Xing W, Liao Q, Viboud C et al (2014) Hand, foot, and mouth disease in China, 2008\u201312: an epidemiological study. Lancet Infect Dis 14:308\u2013318","journal-title":"Lancet Infect Dis"},{"key":"3797_CR36","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.vaccine.2015.03.034","volume":"33","author":"C Zhang","year":"2015","unstructured":"Zhang C, Ku Z, Liu Q et al (2015) High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice. Vaccine 33:2335\u20132341","journal-title":"Vaccine"},{"key":"3797_CR37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1203\/01.pdr.0000238247.86041.19","volume":"60","author":"LY Chang","year":"2006","unstructured":"Chang LY, Hsiung CA, Lu CY et al (2006) Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res 60:466\u2013471","journal-title":"Pediatr Res"},{"key":"3797_CR38","doi-asserted-by":"publisher","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","volume":"8","author":"Z Ku","year":"2013","unstructured":"Ku Z, Ye X, Huang X et al (2013) Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps. PLoS One 8:e57601","journal-title":"PLoS One"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-018-3797-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-018-3797-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-018-3797-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:42:49Z","timestamp":1553647369000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-018-3797-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3797"],"URL":"https:\/\/doi.org\/10.1007\/s00705-018-3797-7","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"10 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}